Brief Research Report
Published on 05 Jun 2024
Clinical development and marketing application review times for novel orphan-designated drugs
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2024.1404922
- 1,329 views
- Frontiers in Medicine
- Regulatory Science
- Articles
Type at least 3 characters
424 articles
Original Research
Published on 05 Jun 2024
Streamlining intersectoral provision of real-world health data: a service platform for improved clinical research and patient care
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2024.1377209
- 1,960 views
- 2 citations
Review
Published on 05 Jun 2024
A decade of collaboration in medicines regulation: healthcare professionals engaging with the European Medicines Agency
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2024.1399947
- 1,632 views
Review
Published on 03 Jun 2024
Navigating the challenges of clinical trial professionals in the healthcare sector
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2024.1400585
- 22,165 views
Review
Published on 03 Jun 2024
Artificial intelligence in healthcare: an Italian perspective on ethical and medico-legal implications
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2024.1343456
- 2,897 views
- 4 citations
Original Research
Published on 31 May 2024
International regulatory and publicly-funded initiatives to advance drug repurposing
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2024.1387517
- 1,462 views
- 2 citations
Original Research
Published on 30 May 2024
Current situation and issues regarding termination of risk management plans in Japan
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2024.1387652
- 1,406 views
- 1 citation
Technology and Code
Published on 27 May 2024
Transforming evidence-based clinical guidelines into implementable clinical decision support services: the CAREPATH study for multimorbidity management
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2024.1386689
- 2,841 views
- 2 citations
Review
Published on 23 May 2024
Leveraging patient experience data to guide medicines development, regulation, access decisions and clinical care in the EU
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2024.1408636
- 4,685 views
- 3 citations
Mini Review
Published on 22 May 2024
Artificial intelligence in drug repurposing for rare diseases: a mini-review
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2024.1404338
- 6,379 views
- 7 citations
Methods
Published on 16 May 2024
OHDSI-compliance: a set of document templates facilitating the implementation and operation of a software stack for real-world evidence generation
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2024.1378866
- 1,335 views
Original Research
Published on 15 May 2024
Artificial intelligence based data curation: enabling a patient-centric European health data space
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2024.1365501
- 5,198 views
- 3 citations
Mini Review
Published on 13 May 2024
Exploring regulatory flexibility to create novel incentives to optimize drug discovery
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2024.1379966
- 1,688 views
- 1 citation
Policy and Practice Reviews
Published on 09 May 2024
Cybersecurity policy framework requirements for the establishment of highly interoperable and interconnected health data spaces
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2024.1379852
- 2,775 views
- 2 citations
Methods
Published on 02 May 2024
Application of the Composite Quality Score (CQS-2B) versus Cochrane’s Risk of Bias tool (Version 2) in systematic reviews of clinical trials – an exploratory study
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2024.1307815
- 803 views
Brief Research Report
Published on 26 Apr 2024
Promoting opioids, a story about how to influence medical science and opinions
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2024.1327939
- 2,342 views
- 3 citations